| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/17/2005 | CN1655785A N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders |
| 08/17/2005 | CN1655783A Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative |
| 08/17/2005 | CN1655782A Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 08/17/2005 | CN1655774A Bis-aromatic alkanols |
| 08/17/2005 | CN1655764A Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 08/17/2005 | CN1654073A Paster for treating tinea unguium |
| 08/17/2005 | CN1654071A Biological fluid film of recombined human keratinized cell growth factor-2 and its preparing process |
| 08/17/2005 | CN1654068A Ointment for treating dermatosis |
| 08/17/2005 | CN1654043A Method for preparing pure Chinese medicinal single prescription aqua agent and use thereof |
| 08/17/2005 | CN1214810C Oral health products for blacking hairs and pilatory effect |
| 08/17/2005 | CN1214804C Chinese medicine for treating face acne |
| 08/17/2005 | CN1214802C Capsule for curing acne and its preparation process |
| 08/17/2005 | CN1214801C Face nursing and beautifying oral liquid |
| 08/17/2005 | CN1214790C Method for preparing isoxazole substituted composition for treating inflammation |
| 08/17/2005 | CN1214787C Use of composition containing undecylenic acid zinc in preparation of drug of curing underarm odour |
| 08/17/2005 | CN1214781C Hybrid matrices and hybrid matrix mixtures |
| 08/17/2005 | CN1214780C Cosmetic composition containing neuropeptide Y receptor antagonist |
| 08/16/2005 | US6930123 Benz(f)indole compounds useful for Inflammatory Diseases |
| 08/16/2005 | US6930118 3-Oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 08/16/2005 | US6930116 Such as 4-chloro-5-(2-phenyl-thiazol-5-yl)-2H-pyrazole-3-carboxylic acid ethyl amide; for inhibiting topoisomerases; treating bacterial infections in mammals |
| 08/16/2005 | US6930111 Substituted heterocyclic compounds |
| 08/16/2005 | US6930108 Nitrogen compounds such as 2-[2-ethoxy-5-(4-ethyl-piperazine-1-sulphonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one, used for prophylaxis of psoriasis, diabetes, alopecia, genetic, sexual, cardiovascular or genetic disorders |
| 08/16/2005 | US6930101 Thiazolopyrimidines useful as TNFα inhibitors |
| 08/16/2005 | US6930085 G-type peptides to ameliorate atherosclerosis |
| 08/16/2005 | US6929798 Compositions and methods for treatment of microbial infections |
| 08/16/2005 | CA2342974C Methods and compositions for inhibition of angiogenesis |
| 08/16/2005 | CA2334344C Method and composition for the treatment of epidermal irritations and infections |
| 08/16/2005 | CA2280985C Compound containing urea and use of the compound in the field of cosmetics and/or dermatology |
| 08/16/2005 | CA2273094C Gel formulations for topical drug delivery |
| 08/16/2005 | CA2252900C Cosmetic composition for rejuvenation of skin without skin irritation |
| 08/11/2005 | WO2005072707A1 Nanoparticle-containing composition and process for producing the same |
| 08/11/2005 | WO2005072697A1 Use of a lyophilisate of dedifferentiated plant cells for skin depigmentation and/or lightening |
| 08/11/2005 | WO2004112837A8 PREPARATION FOR EXTERNAL PERCUTANEOUS ADMINISTRATION CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY DRUG AND INTERLEUKIN-1α PRODUCTION INHIBITOR |
| 08/11/2005 | US20050176964 Nicotinamide derivatives useful as p38 inhibitors |
| 08/11/2005 | US20050176931 Eotaxin : eosinophil chemotactic cytokine |
| 08/11/2005 | US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis |
| 08/11/2005 | US20050176871 Thermoplastic Elastomer-Based Solid Emulsions |
| 08/11/2005 | US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation |
| 08/11/2005 | US20050176822 Phenylacetonitrile derivatives and hair tonics and external preparations for skin containing the derivatives |
| 08/11/2005 | US20050176820 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 08/11/2005 | US20050176817 Anticancer agents; prevention of infections; autoimmune diseases;antiarthritic agents; cystic fibrosis |
| 08/11/2005 | US20050176816 Controlling infections; antiallergens; antiarthritic agents; cardiovascular disorders |
| 08/11/2005 | US20050176815 Malaria therapy |
| 08/11/2005 | US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde |
| 08/11/2005 | US20050176802 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/11/2005 | US20050176796 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 08/11/2005 | US20050176780 2,5-disubstituted 3-mercaptopentanoic acid |
| 08/11/2005 | US20050176762 Tachykinin receptor subtypes NK3 and NK2 (NK neurokinin); various diseases including respiratory system disorders, autoimmune disorders, psychological disorders, skin disorders |
| 08/11/2005 | US20050176756 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 08/11/2005 | US20050176753 controlling signal transduction; anticancer agents; antitumor agnets; atherosclerosis; vision defects; antidiabetic agents; antiinflammatory agents |
| 08/11/2005 | US20050176751 Selective H1 histamine receptor antagonists; bronchial asthma, allergic rhinitis, conjunctivitis, dermatitis, urticaria and other allergic diseases; e.g. 3-(4-[1-(2-methoxyethyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]piperidin-1-ylmethyl)benzoic acid |
| 08/11/2005 | US20050176741 Quinazoline derivative and medicine |
| 08/11/2005 | US20050176731 N-[5-({(2S)-3-[(4-{4-[(4-benzylpiperidin-1-yl)carbonyl]phenyl}cyclohexyl)amino]-2-hydroxypropyl}oxy)-2-hydroxyphenyl]methanesulfonamide; beta 3 receptors agonist; gastrointestinal diseases; antiobesity, antidiabetic, cicatrizing agents, tocolytics, dysmenorrhea, antiglaucomatous; amidation |
| 08/11/2005 | US20050176723 (Halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/11/2005 | US20050176722 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/11/2005 | US20050176714 Pyridazine derivatives |
| 08/11/2005 | US20050176713 Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 08/11/2005 | US20050176712 Integrin expression inhibitor |
| 08/11/2005 | US20050176711 Phthalazine derivatives for treating inflammatory diseases |
| 08/11/2005 | US20050176708 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 08/11/2005 | US20050176694 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity |
| 08/11/2005 | US20050176687 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
| 08/11/2005 | US20050176671 Drug screening; competitive binding; antitumor agents, antiproliferative agents, as promoter providing neuronal cell growth, wound healing, and cerebral injury healing; receptor binding assay, gene expression |
| 08/11/2005 | US20050176060 Crystal structure |
| 08/11/2005 | US20050175991 Using fluid comprising bacteria lysing virus bacteria as tool in cleaning fruits and vegatables |
| 08/11/2005 | US20050175748 Antimicrobial envelopes |
| 08/11/2005 | US20050175647 Compositions for topical application having androgenic actions |
| 08/11/2005 | US20050175646 Cosmetic composition that mimics sebum and the use thereof |
| 08/11/2005 | US20050175643 Fermentation microbe and metabolites, thickener, water, and carbon dioxide; adding water and thickener to carbon dioxide-impermeable sealable container; low speed depressurization to degas raw materials; filling with carbon dioxide; skin and atopic disorders; wound healing agents; dermatitis, pruritus |
| 08/11/2005 | US20050175641 Homogenous liquid blend of hydrophilic polyvinyl alcohol, hydroxypropylmethyl cellulose, hydroxypropyl cellulose , polyvinyl pyrollidone, carbomer, maleic anhydride-methyl vinyl ether decadiene cross polymer and/or hydroxypropylguar; and hydrophobic ethyl cellulose; anti-onychomycoses agents; acne |
| 08/11/2005 | US20050175640 Cyclodextrin and adrenocortical steroid dissolved in aqueous solution; dextran or pullulan; mixture with xyloglucan, trehalose, laminaran, pectin, and krestin; grape sugar, mutan, lentinan, sodium chloride, and/or potassium chloride; side effect reduction; psoriasis, atopic diseases |
| 08/11/2005 | US20050175637 Methods for enhancing wound healing |
| 08/11/2005 | US20050175565 Use of taurine for the treatment of alopecia |
| 08/11/2005 | US20050175554 as a UV filter in cosmetic preparation; skin and hair; R3-substituted 2-(4-aminophenyl)-benzothiazole by alkylation with the appropriate haloalkanes/haloaralkanes using a base |
| 08/11/2005 | CA2554243A1 Dermatologic soft gel compositions |
| 08/11/2005 | CA2554025A1 Enhancement of anti-androgenic activity by a combination of inhibitors targeting different steps of a steroid-dependent gene activation pathway and uses thereof |
| 08/11/2005 | CA2552391A1 Oligonucleotide and the use thereof for modulating an isoform c beta-1 protein-kinase in the form of a skin depigmentation agent |
| 08/10/2005 | EP1561467A1 Composition for restoring damaged skin |
| 08/10/2005 | EP1561464A2 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors |
| 08/10/2005 | EP1560855A1 Polysaccharide of echinacea angustifolia |
| 08/10/2005 | EP1560837A2 Novel ampiphilic derivatives of alpha-c-phenyl n-tert-butyl nitrone |
| 08/10/2005 | EP1560828A1 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 08/10/2005 | EP1560817A1 Methods and compositions of novel triazine compounds |
| 08/10/2005 | EP1560591A2 Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto |
| 08/10/2005 | EP1560589A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 08/10/2005 | EP1560562A2 Dermastick thickened ointment |
| 08/10/2005 | EP1345946B1 Macroheterocylic compounds useful as kinase inhibitors |
| 08/10/2005 | EP1343826B1 Polysaccharide compound having immune stimulating activity |
| 08/10/2005 | EP1339679B1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 08/10/2005 | EP1301207B1 Compositions for treating bacterial infections, containing an oxazolidinone compound, sulbactam and and ampicillin |
| 08/10/2005 | EP1292581B1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists |
| 08/10/2005 | EP1208103B1 Reverse-turn mimetics and methods relating thereto |
| 08/10/2005 | CN1653075A C-aryl glucoside SGLT2 inhibitors and method |
| 08/10/2005 | CN1653068A Novel diazabicyclic biaryl derivatives |
| 08/10/2005 | CN1653059A Macrocyclic compounds useful as pharmaceuticals |
| 08/10/2005 | CN1653040A HIF hydroxylase inhibitors |
| 08/10/2005 | CN1653036A Amino acids with affinity for the alpha-2-delta-protein |
| 08/10/2005 | CN1652810A Immunosuppressant compounds, methods and uses related thereto |
| 08/10/2005 | CN1652808A Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic |
| 08/10/2005 | CN1652786A Fluorinated 4-azasteroid derivatives as androgen receptor modulators |